The effects of enteral artificial amniotic fluid-containing erythropoietin on short term outcomes of preterm infants
The effects of enteral artificial amniotic fluid-containing erythropoietin on short term outcomes of preterm infants
نویسندگان: محمدباقر حسینی , سینا رئیسی , میثم بهتری , هادی ولیزاده , رویا صبوحی خامنه , حمید اعظم پور
کلمات کلیدی: amniotic fluid; erythropoietin; necrotizing enterocolitis; preterm infant
نشریه: 34107 , 3 , 61 , 2019
| نویسنده ثبت کننده مقاله |
سینا رئیسی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات سلامت کودکان |
| کد مقاله |
71242 |
| عنوان فارسی مقاله |
The effects of enteral artificial amniotic fluid-containing erythropoietin on short term outcomes of preterm infants |
| عنوان لاتین مقاله |
The effects of enteral artificial amniotic fluid-containing erythropoietin on short term outcomes of preterm infants |
| ناشر |
6 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Necrotizing Enterocolitis (NEC) is a common devastating gastrointestinal
disease, which usually develops in premature infants. Erythropoietin (EPO) as
a hematopoietic hormone produced by the kidney can also be naturally found
in amniotic fluid and breast milk. There is some evidence that supports the
contribution of EPO in the prevention of inflammation and intestinal tissue
repair. This study was aimed to determine if oral administration of artificial
amniotic fluid with or without EPO would protect preterm infants against NEC
and improve the certain neonatal outcomes. In this study, 150 preterm infants
with gestational age 28 weeks or less and birth weight 1250 grams or less
were enrolled. The infants were divided randomly into 3 groups: 1) Control
group (n=50) with routine feeding protocol without any administration; 2)
Amniotic fluid group (n=50) with 5mL/kg synthetic amniotic fluid; 3) EPO
group (n=50) with RhuEPO dissolved in the synthetic amniotic fluid. The
administrations of the study solution were started 3 days after the birth and
were continued for 3 weeks (21 days). The infants in the study groups were
followed up until discharge and the frequency of NEC, mortality, and other
complications of the disease among the groups were compared. The mortality
rate in preterm infants of the amniotic fluid and EPO groups were significantly
lower than in the control group (p=0.027). We couldn’t find any significant
differences in the frequency of NEC and other complications among the three
study groups. The administration of synthetic amniotic fluid (with or without
EPO) in preterm infants may decrease the mortality rate. Use of EPO in
synthetic amniotic fluid did not affect the frequency of NEC. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| pdf_TJP_1971.pdf | 1398/12/05 | 545540 | دانلود |